The nation of Zimbabwe has turned down a major US healthcare agreement worth 367 million US dollars (£272m) over five years due to the United States' demand for confidential data.
The decision was revealed following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesman has since stated that the US was requesting health data for scientific study and profit but was unwilling to share the benefits from future treatments.
"We must now begin the challenging and unfortunate process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for more talks to secure a deal suitable to all parties so the country's critical HIV programme can proceed.
Broader Background
This development follows a comparable situation in Kenya, where a court halted a related deal with the US after legal challenges were filed about the security of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and responsibility.
As per statements, Sixteen nations in Africa have to date agreed to similar agreements, representing over $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding assurance of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the end products would be available to our citizens if a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems previously established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.
"This framework is intended to ensure that when a nation provides its data, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
These objections over the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage continued discussions with our American counterparts on how future collaboration might be structured in a manner that respects the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but suggested that negotiations should continue since much of the nation's HIV programmes relied on foreign aid.
"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group added.
The situation highlights the complex challenges between receiving vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.